Industry News
Determining the risk of prostate cancer death
Researchers have identified a prognostic biomarker, the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. [ + ]
Geoscientists win travel grants
The Australian Geoscience Council and the Australian Academy of Science have announced the winners of the 34th International Geological Congress Travel Grants, worth $30,000. [ + ]
Wrinkle-free fabric that's environmentally friendly
Researchers have reported a method for making wrinkle-resistant cotton fabrics that is said to be more environmentally friendly and cost-effective than current techniques. [ + ]
US patent granted for IMP731 antibody
The United States Patent and Trademark Office has granted a patent for the IMP731 antibody, owned by Australian biotech company Prima BioMed. [ + ]
Healthcare executive John Chiplin joins Sienna Cancer Diagnostics
Melbourne-based biotech company Sienna Cancer Diagnostics has announced the appointment of Dr John Chiplin to its board of directors. [ + ]
Are aliens extinct?
Why does evidence of alien life continue to elude Earth's scientists? Is it because such life never existed at all, or because it has already gone extinct? [ + ]
Predicting cancer immunotherapy response
IRX Therapeutics and ImmunID have entered into a collaboration to predict patients' response to the IRX-2 immunotherapy candidate using the ImmunTraCkeR assay. [ + ]
Chief Scientist Ian Chubb bids farewell
Professor Ian Chubb has completed his appointment as Australia's seventh Chief Scientist after almost five years in the role. [ + ]
Imugene to develop mimotope-based immunotherapies
Imugene has announced the extension of its partnership with the Medical University of Vienna to discover and develop new mimotope-based immunotherapies against validated and new oncology targets. [ + ]
How reptile embryos cope with climate change
Western Australian researchers have discovered that the ability of sea turtles to respond to heat stress varies with their genes. [ + ]
Putting a hex on leukaemia
Scientists have discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models and could also be a key target for new therapies for human leukaemia. [ + ]
Studying sepsis with protein patterns
A Swedish research team has developed a way to measure hundreds of proteins in a single blood sample, using these protein patterns to determine the severity of sepsis (blood poisoning) in individual patients.
[ + ]Clinical trial disaster
A Phase 1 clinical trial has gone seriously awry, with one volunteer now dead and others with serious, possibly irreversible, neurological damage. [ + ]
Zoetis to evaluate anti-infective product for animals
Zoetis will evaluate the potential applications of Detach — a non-antibiotic, anti-infective product — for veterinary use in food production animals. Detach is a plant-based product that will help address concerns around the overuse of antibiotics in production animals. [ + ]
GEA gets an in-house test lab
GEA's new in-house laboratory will enable the company's engineers to carry out extensive tests on the properties of powders and to design powder packaging systems based on scientifically obtained data to optimise production and reduce waste. [ + ]